Publicacions
-
Prieto C, Stam RW, Agraz-Doblas A, Ballerini P, Camós-Guijosa M, Castaño J, Marschalek R, Bursen A, Varela I, Bueno C and Menendez P.
Activated KRAS Cooperates with MLL-AF4 to Promote Extramedullary Engraftment and Migration of Cord Blood CD34(+) HSPC But Is Insufficient to Initiate Leukemia
CANCER RESEARCH . 76(8): 2478-2489. Nº de cites: 32
-
Wlodarski MW, Hirabayashi S, Pastor V, Starý J, Hasle H, Masetti R, Dworzak M, Schmugge M, van den Heuvel-Eibrink M, Ussowicz M, De Moerloose B, Català-Temprano A, Smith OP, Sedlacek P, Lankester AC, Zecca M, Bordon V, Matthes-Martin S, Abrahamsson J, Kühl JS, Sykora KW, Albert MH, Przychodzien B, Maciejewski JP, Schwarz S, Göhring G, Schlegelberger B, Cseh A, Noellke P, Yoshimi A, Locatelli F, Baumann I, Strahm B, Niemeyer CM and EWOG-MDS.
Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents
Blood . 127(11): 1387-1397. Nº de cites: 264
-
Cseh AM, Niemeyer CM, Yoshimi A, Català-Temprano A, Frühwald MC, Hasle H, van den Heuvel-Eibrink MM, Lauten M, De Moerloose B, Smith OP, Bernig T, Gruhn B, Kulozik AE, Metzler M, Olcay L, Suttorp M, Furlan I, Strahm B and Flotho C.
Therapy with low-dose azacitidine for MDS in children and young adults: a retrospective analysis of the EWOG-MDS study group
BRITISH JOURNAL OF HAEMATOLOGY . 172(6): 930-936. Nº de cites: 24
-
Berrueco R, Alonso-Saladrigues A, Martorell-Sampol L, Català-Temprano A, Ruiz-Llobet A, Toll T, Torrebadell-Burriel M, Naudo-Lahoz M, Camós-Guijosa M and Rives-Solà S.
Outcome and toxicities associated to chemotherapy in children with acute lymphoblastic leukemia and Gilbert syndrome. Usefulness of UGT1A1 mutational screening
PEDIATRIC BLOOD & CANCER . 62(7): 1195-1201. Nº de cites: 8
-
Barneda-Zahonero B, Collazo O, Azagra A, Fernández-Duran I, Serra-Musach J, Islam AB, Vega-García N, Malatesta R, Camós-Guijosa M, Gómez A, Román-González L, Vidal A, López-Bigas N, Villanueva A, Esteller M and Parra M.
The transcriptional repressor HDAC7 promotes apoptosis and c-Myc downregulation in particular types of leukemia and lymphoma
CELL DEATH & DISEASE . 6: 1635. Nº de cites: 36
-
Niemeyer CM, Loh ML, Cseh A, Cooper T, Dvorak CC, Chan R, Xicoy B, Germing U, Kojima S, Manabe A, Dworzak M, De Moerloose B, Starý J, Smith OP, Masetti R, Català-Temprano A, Bergstraesser E, Ussowicz M, Fabri O, Baruchel A, Cavé H, Zwaan M, Locatelli F, Hasle H, van den Heuvel-Eibrink MM, Flotho C and Yoshimi A.
Criteria for evaluating response and outcome in clinical trials for children with juvenile myelomonocytic leukemia
HAEMATOLOGICA . 100(1): 17-22. Nº de cites: 29
-
Pennesi E, Brivio E, Ammerlaan ACJ, Jiang Y, Van der Velden VHJ, Beverloo HB, Sleight B, Locatelli F, Brethon B, Rossig C, Engstler G, Nilsson A, Bruno B, Petit A, Bielorai B, Rizzari C, Rialland F, Rubio-San-Simón A, Sirvent FJB, Diaz-de-Heredia C, Rives-Solà S and Zwaan CM.
Inotuzumab ozogamicin combined with chemotherapy in pediatric B-cell precursor CD22+ acute lymphoblastic leukemia: results of the phase IB ITCC-059 trial.
HAEMATOLOGICA . : .
-
Benítez L, Castro-Barquero S, Fàtima Crispi Brillas, Youssef L, Crovetto F, Fischer U, Kameri E, Bueno C, Camós-Guijosa M, Menéndez P, Heinäniemi M, Borkhardt A and Gratacós E.
MATERNAL LIFESTYLE AND PRENATAL RISK FACTORS FOR CHILDHOOD LEUKEMIA: A REVIEW OF THE EXISTING EVIDENCE.
FETAL DIAGNOSIS AND THERAPY . : .
-
Velasco Puyó P, Tagarro A, Garcia-Obregon S, Villate Bejarano O, Moraleda C, Huerta Aragonés J, Bardón Cancho EJ, Faura A, Galán-Gómez V, Escobar Fernández L, Lendinez-Molinos F, Herrero Velasco B, Ureña Horno L, Domínguez-Pinilla N, Pascual Gazquez JF, Nova Lozano C, Osuna-Marco M, Marín-Cruz I, Gomez Pastrana I, Garcia de Andoin Barandiaran N, Gallego Mingo N, Portugal Rodríguez R, Cañete A, Pareja León M, Castrillo Bustamante S, Tallón García M, Gónzalez-Prieto A, Solé-Rodríguez M, González Cruz M, Soriano-Arandes A, Mota M, Pérez-Hoyos S, Moreno L and Astigarraga I.
Cancer is not a risk factor for severe COVID-19 in children, except in patients with recent allogeneic hematopoietic stem cell transplantation or comorbidities.
PEDIATRIC BLOOD & CANCER . : .
-
Wu JH, Pennesi E, Bautista F, Garrett M, Fukuhara K, Brivio E, Ammerlaan ACJ, Locatelli F, van der Sluis IM, Rossig C, Chen-Santel C, Bielorai B, Petit A, Starý J, Díaz-de-Heredia C, Rives-Solà S, O'Marcaigh A, Rizzari C, Engstler G, Nysom K, Rubio-San-Simón A, Bruno B, Bertrand Y, Brethon B, Rialland F, Plat G, Dirksen U, Sramkova L, Zwaan CM and Huitema ADR.
Population Pharmacokinetics of Inotuzumab Ozogamicin in Pediatric Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia: Results of Study ITCC-059.
CLINICAL PHARMACOKINETICS . : .